FORT LAUDERDALE, Florida – After a successful showing at May’s all-virtual Efficient Collaborative Retail Marketing (ECRM) conference, Bedford, Kentucky-based PHARM CBD plans to expand its product sales into the U.S. retail market. The ECRM conference is an opportunity for established and emerging brands to meet with retailers in their field, in the hopes of having their products sold through some of the largest online and in-store sellers in the United States.
The ECRM program on “Healthy Living, Vitamin and Nutrition” was a unique event, since social distancing procedures required the conference to be held entirely online. The sudden challenge in meeting format has drawn attention to brands who are able to adapt, and demonstrate significant tech-literacy, in what can be called the new age of business-to-business marketing.
Throughout the conference, representatives of PHARM CBD met with some of the biggest names in retail throughout the U.S. in a fast-paced virtual format, giving each company only a limited time to impress prospective buyers. But despite the obstacles of adjusting to the rapid-fire buying style, PHARM CBD successfully landed a host of new contacts in the retail world.
One of PHARM CBD’s biggest strengths while shopping products around to new buyers is its strict adherence to quality and potency standards. Not only does PHARM CBD test all of its products through ISO 17025 accredited laboratories, but PHARM CBD said that its products were found to have such consistent levels of potency, that these laboratories now use PHARM CBD products as the control group for all other CBD testing.
PHARM also boasts a model of “seed-to-sale” production. Unlike CBD companies that source ingredients far and wide, PHARM grows and processes its own hemp, and packages its products. This allows a higher level of control and quality assurance not found in larger companies that need to rely on a thinly spread supply chain.
Another advantage of this “tight ship” manufacturing model, according to PHARM, is that all of its products ship at an impressively fast rate as compared to their competition. Rather than waiting weeks after receiving a sales order, PHARM is able to get products out to customers at a rapid pace, because its production is streamlined. The company is also fully family-owned and operated, ensuring the greatest level of knowledge and consistency with every element of its process.
PHARM said that, while it was only able to share a brief time with buyers from the ECRM conference, it seems to have made an impact. The company is planning to continue its 2020 expansion both online and in-stores across the U.S.
